PT-141 Peptide

PT-141 is a pharmaceutical-grade synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH) that targets melanocortin 4 receptors in the central nervous system. Unlike traditional approaches that affect vascular function, this precision-formulated peptide works through neural pathways to enhance sexual desire and function in both men and women. FDA-approved for hypoactive sexual desire disorder in premenopausal women, our GMP-compliant preparation demonstrates efficacy for addressing sexual function challenges through its unique mechanism of central activation rather than peripheral vasodilation.

Enhanced Sexual Arousal and Desire: It has been shown to enhance sexual arousal and may improve overall sexual satisfaction in both men and women.

Melanocortin Receptor Activation: It works by activating melanocortin receptors in the brain, particularly MC4R and MC1R, which play a role in sexual arousal and desire.

Known potential side effects:

• Flushing: About 40% of experienced redness and warmth in the face, neck, and chest
• Headaches: Around 20% reported experiencing headaches
• Nausea: About 10-15% of users and usually subsides within a few hours
• Skin irritation: Redness, pain, and itching at the injection site are fairly common
• Decreased appetite: Some users report a temporary loss of appetite